T7326-1KU Display Image

Thrombin from bovine plasma, >=60 NIH units/mg protein (biuret)

Code: T7326-1KU D2-231

Analysis Note

The NIH assay procedure uses 0.2 mL of diluted plasma (1:1 with saline) as a substrate and 0.1 mL of thrombin sample (stabilized in a 1% buffered albumin soluti...


read more

Your Price
£62.00 EACH

Analysis Note

The NIH assay procedure uses 0.2 mL of diluted plasma (1:1 with saline) as a substrate and 0.1 mL of thrombin sample (stabilized in a 1% buffered albumin solution) based on a modification of the method of Biggs. Only clotting times in the range of 15-25 seconds are used for determining thrombin concentrations.

Activity is expressed in NIH units obtained by direct comparison to a NIH Thrombin Reference Standard, Lot K.

Application

Thrombin from bovine plasma may be used:for the generation of fibrin from fibrinogen embedded in microbubblesfor the cleavage of hydrogenase maturation protein (HypF-N) from the nickel resinas revitalization model to mimic blood fabrication in root canal

Thrombin is used for site specific cleavage of recombinant fusion proteins containing an accessible thrombin recognition site for removal of affinity tags. Thrombin has been used in a study to evaluate coagulation abnormalities in acute liver failure.

Biochem/physiol Actions

Serine protease that selectively cleaves Arg-Gly bonds in fibrinogen to form fibrin and fibrinopeptides A and B.

General description

Thrombin is the final coagulation protease in regard to hemostasis, promoting both procoagulant and anticoagulant effects. Thrombin comprises of A-chain and B-chain with the catalytic pocket. The C-terminal regions has a fibrinogen recognition site (FRS) and a heparin binding site (HBS). The main function of thrombin is cleavage of fibrinogen to fibrin. It coordinates the coagulation cascade and coordinates with protease-activated receptors (PARs) to regulate physiological functions. High levels of thrombin causes neurotoxicity in dopaminergic neurons and contribute to the progression of parkinsons disease. Altered thrombin levels modulates coagulation pathway in multiple sclerosis. Patients with coronary artery disease (CAD) show elevated levels of thrombin.

Other Notes

View more information on thrombin at www.sigma-aldrich.com/enzymeexplorer.

Packaging

1000, 10000 units in poly bottle

Physical form

Lyophilized powder containing sodium chloride and Tris-HCl, pH 7.0

Preparation Note

Traditional thrombin products are activated with bovine brain thromboplastin, whereas T7326 is activated with bovine lung thromboplastin and does not contain any bovine brain products in its preparation.

Unit Definition

Activity is expressed in NIH units obtained by direct comparison to a NIH thrombin reference standard.

compositionProtein, ≥50%
formlyophilized powder
Quality Level200
specific activity≥60 NIH units/mg protein (biuret)
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
T7326-10KU
Unit:EACH
List Price: £359.00
Source:List Price
ADD
Cas Number9002-04-4
This product has met the following criteria: